Showing 4081 - 4090 of 4441 for "IP transactions" with applied filters
11 January 2023 by Rob Rodrigues, Danielle Altomari, Priscila Figueiredo, Ivan Domith
The healthcare sector in Brazil is one of the most important in the world in view of the size of the population (+220 million people) and the availability of a universal public healthcare system. The action of antibodies as therapeutic agents may involve processes of neutralization, opsonization and activation of immune complement system, transforming them into a progressively desirable tool in medicine. In view of this, the interaction between IP and these innovative therapies deserves special attention.
01 December 2022 by Licks Attorneys - Brazil
Licks Attorneys announced the promotion of two attorneys at law to partners
28 October 2022 by Bryn Aarflot and Protector IP
Bryn Aarflot and Protector IP join forces, becoming one of the strongest professional environments within intellectual property in Norway
04 October 2022 by Hoffmann Eitle
Hoffmann Eitle today announced that it has selected Symphony, from MaxVal Group, as its new Intellectual Property Management System to serve as an integral part of a firm-wide transformation initiative
14 February 2022 by LexOrbis
Manisha Singh and Niti Vyas of LexOrbis consider the findings of a Delhi High Court case that looks at how registered trademarks are used as keywords
03 November 2021 by Manisha Singh and Simrat Kaur
Manisha Singh and Simrat Kaur analyse the Supreme Court's decision regarding section 31d of the Copyright Act and Rule 29(4) of the Copyright Rules
01 September 2021 by Manisha Singh and Pankaj Musyuni
Manisha Singh and Pankaj Musyuni of LexOrbis discuss how patent rights are impeding access to medicines and what can be done to minimise the damage caused by COVID-19
09 August 2021 by Jason Cheah and Chew Qi-Guang
Jason Cheah and Chew Qi-Guang of Henry Goh & Co discuss the latest updates in Malaysian IP law and the proposed legislative changes
16 June 2021 by Lili Wu, Ying Li, Yulian Hu and Linlin Zhang
Lili Wu, Ying Li, Yulian Hu and Linlin Zhang of Han Kun Law Offices explain how China’s drug-patent linkage system promotes and encourages innovation and development of the pharmaceutical industry
10 June 2021 by Crystal J Chen and Nick J C Lan
Crystal J Chen and Nick J C Lan of Tsai Lee & Chen examine the case law on post-sale confusion in other jurisdictions and considers how Taiwan’s IP Court has embraced the concept